NKCL Bio Group’s NK Immune
Water has won the Grand Prize in the deep sea water category at the ‘2022 Customers
Most Recommended Brand Awards’ hosted and sponsored by The JoongAng and The
Economist on the 20th this month.
The awards select the brands
that have been certified by customers for its reliability and professionalism through
a consumer perception survey and expert review on brand quality and
satisfaction, to present indicators for smart consumption activities to
consumers. NK Immune Water received the Brand Grand Prize in the deep sea water
category in recognition of its excellent quality and customer satisfaction with
future-oriented and sustainable branding.
NKCL Bio Group is a Korean biotech company
that researches and develops NK immune cell therapeutics, who is leading the
mass production and popularization of NK immune cell therapy products through
the GMP automatic culture system incorporating artificial intelligence. In
addition, it plans to operate the CDMO business with proven technology.
NK Immune Water from NKCL Bio Group is a
high-mineral premium deep-sea water that contains abundant minerals necessary
for our body, such as magnesium and calcium. Deep sea water is only available
in five countries, in the world, including Korea, so it has a higher scarcity
value.
In
addition, NK Immune Water is ‘water close to my body’, and it has a mineral
balance similar to that of human body fluid (magnesium 3: calcium 1: potassium
1), thus increasing the absorption rate in our body. The minerals contained in
NK Immune Water can help improve the immune system of our body through various
functions such as blood pressure control, immunity improvement, and diabetes
improvement.
NK Immune Water of NKCL Bio Group was
recognized as the brand of the year in 2021 by winning the Grand Prize of 'Best
Brand Chosen by Consumers' hosted by the Chosun Media, while NKCL Bio Group was
recognized as a successful immune care brand by winning the grand prize at the
‘9th 2021 Future Creative Management Excellent Company’ for two consecutive years,
showing the possibility of expanding into various industrial fields through
products devised with ‘immune care’.
An official from NKCL Bio Group said, “Last year,
NKCL Bio Group has built a 1:1 Personalized Immune-care Platform through
differentiated immune cell culture technology. In 2022, we plan to focus on
expanding the platform nationwide.” NKCL Bio Group is ahead of opening the ‘NKCL
Immune Treatment Center’ in cooperation with Dongtan Hospital and Clinic in
February 2022. ‘NKCL Immune Treatment Center’ is a comprehensive treatment flex
mall, including Immune Checkup Center, Immune Treatment Center, Immune
Drugstore and Immune Bakery Café.
